TMC Life Sciences (0101.KU) - Malaysia
(3rd) quarter ended Mar 31:
Figures Are In Ringgit (MYR).
2026 2025
Revenue 89,701,000 89,872,000
PreTax Profit 2,749,000 52,000
Net Profit 1,758,000 -806,000
Earnings Per Share 0.10 Sen -0.05 Sen
Dividend 0.00 Sen 0.00 Sen
9 months ended Mar 31:
Revenue 293,675,000 252,265,000
PreTax Profit 18,653,000 4,018,000
Net Profit 12,732,000 1,183,000
Earnings Per Share 0.73 Sen 0.07 Sen
Dividend 0.00 Sen 0.00 Sen